Jump to content

Butaperazine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DePiep (talk | contribs) at 15:56, 2 April 2016 (Remove redundant parameters InChI, InChIKey (StdInChI, StdInChIKey are used). See Talk (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Butaperazine
Clinical data
ATC code
Identifiers
  • 1-[10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazin-2-yl]butan-1-one
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.010.450 Edit this at Wikidata
Chemical and physical data
FormulaC24H31N3OS
Molar mass409.59 g/mol g·mol−1
3D model (JSmol)
  • O=C(c2cc1N(c3c(Sc1cc2)cccc3)CCCN4CCN(C)CC4)CCC
  • InChI=1S/C24H31N3OS/c1-3-7-22(28)19-10-11-24-21(18-19)27(20-8-4-5-9-23(20)29-24)13-6-12-26-16-14-25(2)15-17-26/h4-5,8-11,18H,3,6-7,12-17H2,1-2H3 checkY
  • Key:DVLBYTMYSMAKHP-UHFFFAOYSA-N checkY
  (verify)

Butaperazine (Repoise, Tyrylen) is a typical antipsychotic of the phenothiazine class.[1]

See also

References

  1. ^ "Evaluation of a new antipsychotic agent. Butaperazine maleate (repoise maleate)". JAMA: the Journal of the American Medical Association. 206 (10): 2307–8. December 1968. doi:10.1001/jama.206.10.2307. PMID 4386884.


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Butaperazine&oldid=713200460"